Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Vasogen and Grupo Ferrer to commercialize Celacade in Europe

Vasogen has announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), to commercialize Vasogen's Celacade technology for the treatment of chronic heart failure in the European Union and in certain Latin American countries.

19 Apr 2007

Link between psoriasis and diabetes and atherosclerosis

Psoriasis is a chronic skin condition characterized by thick, red, scaly plaques that itch and sometimes bleed, causing considerable discomfort and emotional stress for patients.

19 Apr 2007

Treatment costs fall and quality improves when patients use self-treatment tools

Encouraging patients to become involved in providing their own care can reduce the cost and improve the quality of long-term medical treatment, say researchers from Massachusetts General Hospital and Massachusetts Institute of Technology in PLoS Medicine this week.

18 Apr 2007

Gleevec available to patients in post-surgical GIST study

Investigators will begin offering Gleevec(R) (imatinib mesylate)* tablets to patients receiving placebo in a major North American clinical trial after an interim analysis showed participants with Kit-positive gastrointestinal stromal tumors treated with Gleevec following surgery were significantly less likely to experience a return of their cancer compared to those not taking this innovative therapy.

15 Apr 2007

Monitoring chronic heart failure patients' health by phone helps

Monitoring patients' health by phone can make a real difference to people with chronic heart failure, according to a study published on bmj.com.

15 Apr 2007

Cytokinetics initiates of phase II clinical trial for CK-1827452

Cytokinetics has announced the initiation of a Phase II clinical trials program evaluating CK-1827452, a novel cardiac myosin activator for the potential treatment of patients with either acutely decompensated or chronic heart failure.

15 Apr 2007

Report reveals cost of type 2 diabetes complications

A first-of-its-kind report looking at the prevalence and cost of type 2 diabetes complications shows that an estimated three out of five people (57.9 percent) with type 2 diabetes have at least one of the other serious health problems commonly associated with the disease, and that these health problems are taking a heavy financial toll on the United States.

11 Apr 2007

Breakthrough Australian pump could give heart patients new hope

Lead researcher Associate Professor Andy Tan said the heart pump's innovative design was based on a double-output centrifugal model that pushed the blood in a counter direction to ensure correct flow through both sides of the heart, and is the subject of a patent application.

11 Apr 2007

Abbott opens biotech facility in Puerto Rico

"This new facility is a key milestone for Abbott as we move to focus our resources and future growth on biologic and potent-drug manufacturing," said Lawrence Kraus, vice president of manufacturing, global pharmaceutical operations, Abbott.

11 Apr 2007

Brain's reaction to stress can damage a vulnerable heart

British scientists say they have found that a part of the brain responsible for functions such as learning and memory can also destabilise the heart during times of stress.

11 Apr 2007

Heart study observes 20th year in Forsyth County

Because of the 4,035 Forsyth County residents who participated in a long-running study of heart disease risk factors, researchers at Wake Forest University Baptist Medical Center and colleagues have made major findings such as how being overweight is associated with becoming disabled and that passive smoking increases the risk of hardening of the arteries.

9 Apr 2007

Alteon expands agreement with Biorap Technologies

Alteon has announced that it has entered into an expanded licensing agreement with BioRap Technologies, the commercialization arm of the Rappaport Family Institute for Research, Technion University, Israel, for all diagnostic devices or products for predictive purposes in vascular or cardiac diseases, including diagnostic assays for the measurement of the haptoglobin protein (Hp).

7 Apr 2007

iIbuprofen may increase likelihood of heart problems in osteoarthritis patients

The common painkiller, ibuprofen, may boost the likelihood of heart problems in high risk patients who have osteoarthritis, suggests research published ahead of print in the Annals of the Rheumatic Diseases.

5 Apr 2007

Heart muscle cell death is an active and ongoing process in heart failure

Using a nuclear medicine technique and molecular imaging to "see" programmed cell loss, the body's normal way of getting rid of unneeded or abnormal cells, may help in early identification of those individuals who are at risk of developing heart failure, say researchers in the April Journal of Nuclear Medicine.

3 Apr 2007

Sodium Bicarbonate vs. Sodium Chloride in persons undergoing coronary angiography

In patients undergoing cardiac catheterization, contrast dye injection can sometimes cause contrast-induced nephropathy (CIN), otherwise known as acute renal failure.

3 Apr 2007

Tilarginine does not reduce risk of death after heart attack

The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.

2 Apr 2007

Xenotransplantation - what are the barriers?

Given the huge shortage of donor organs, researchers have been trying to find ways to transplant animal organs across different species (known as "xenotransplantation"), with the eventual aim of transplanting animal organs into humans.

2 Apr 2007

African Americans may be at higher risk of heart failure because of racial variations in heart muscle's pumping ability

Scientists have known for nearly a decade that African Americans have higher rates of hospitalization for heart failure than other major U.S. racial or ethnic groups, but until now they have had limited information other than socio-economic and demographic characteristics to explain why this is so.

2 Apr 2007

Diabetes and high blood pressure play a much greater role heart failure

Diabetes and high blood pressure, two conditions rooted in genetics and environmental surroundings, play a much greater role than race alone in determining who is mostly likely to develop heart failure, according to the latest study from cardiologists at Johns Hopkins.

1 Apr 2007

New treatments and interventions for chronically impaired cardiac patients

Whether a patient is awaiting a heart transplant or living with chronic heart failure, cardiologists are continuously looking for new therapies that address short-term and/or long-term needs of chronically impaired cardiac patients.

30 Mar 2007